Profusa, Inc. (PFSA)
Profusa, Inc., a digital health technology company, develops bioengineered sensors for body to detect and continuously transmit clinical-grade data for personal and medical use in the United States. It offers the Lumee Oxygen Platform to monitor compromised tissue for peripheral artery disease, chronic wounds, and reconstructive surgery. The company researches and develops the Lumee Glucose Platform which is designed to monitor glucose levels in interstitial fluid. Profusa, Inc. is based in Berkeley, California.
Sector: Surgical & Medical Instruments & Apparatus
Industry: Medical - Devices
Profusa, Inc. Common Stock
NASDAQ:PFSAHealthcare · Medical - Devices
AHAfter hours+0.00%$0.6171
Prev close$0.6184-0.21%Close$0.61710.00%Now$0.6171
Close$0.6171-0.21%
Mkt Cap$374K
Float465K
O/S606K
VOL215K sh
$ Vol$136K
RVOL0.09×
Inst Own0.7%
SI16.8%
Dilution
Financials Summary
Revenue$0
Net Income-$35.82M
Total Assets$3.77M
Free Cash Flow-$16.26M
Debt & Equity
Total Debt$14.81M
Total Equity-$26.66M
Shares Outstanding
Short Interest
Split History3 splits · 3 reverse
2-year cumulative
1:7,500Over cap
Past the 1:250 Nasdaq cap, ineligible for a bid-price compliance period
- 1:4Reverse splitAug 17, 20264 shares → 1
- 1:25Reverse splitJul 7, 202625 shares → 1
- 1:75Reverse splitFeb 9, 202675 shares → 1
Balance Sheet Details
Assets$3.77M
Liabilities$30.43M
Accounts Receivable$0
Accounts Payable$7.34M
Inventory$0
PP&E (Net)$8K
Goodwill$0
Intangible Assets$0
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Revenue | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | - | - | - | - | - |
| Cost of Revenue | $0 | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 | $0 |
| Gross Margin | - | - | - | - | - |
| Research and Development | $2.8M | $1.61M | $2.04M | $4.2M | $7.66M |
| Selling, General, and Administrative | $24.9M | $2.99M | $4.08M | $5.24M | $4.77M |
| Other | -$14.48M | -$100K | -$45K | $1.7M | -$742K |
| Total Operating Expenses | $13.22M | $4.5M | $6.07M | $11.14M | $11.69M |
| Operating Income (EBIT) | -$13.22M | -$4.5M | -$6.07M | -$11.14M | -$11.69M |
| Operating Margin | - | - | - | - | - |
| Interest Expense | $5.09M | $4.42M | $4.28M | $6.27M | $4.08M |
| Interest Income | $0 | $0 | $0 | $0 | $0 |
| Other Income (Expense) | -$22.6M | -$4.73M | -$4.21M | -$9.08M | $1.38M |
| Income Before Tax (EBT) | -$35.82M | -$9.23M | -$10.28M | -$20.22M | -$10.31M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$35.82M | -$9.23M | -$10.28M | -$20.22M | -$10.31M |
| Net Income Margin | - | - | - | - | - |
| Supplementary Data | |||||
| EPS | -107.01 | -357.13 | -76.65 | -62.74 | -31.99 |
| Diluted EPS | -107.01 | -357.13 | -76.65 | -62.74 | -31.99 |
| Weighted Average OS | 334,770 | 25,844 | 134,134 | 322,249 | 322,249 |
| EBITDA | -$30.73M | -$4.81M | -$6M | -$13.22M | -$5.05M |
| EBITDA Margin | - | - | - | - | - |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Assets | |||||
| Current Assets | |||||
| Cash and Cash Equivalents | $1.78M | $191K | $142K | $78K | $856K |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Cash and Short-Term Investments | $1.78M | $191K | $142K | $78K | $856K |
| Accounts Receivable | $0 | $0 | $45K | $0 | $38K |
| Inventory | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $1.45M | $0 | $0 | $82K | $64K |
| Total Current Assets | $3.76M | $260K | $333K | $160K | $958K |
| Long-Term Assets | |||||
| Property, Plant & Equipment Net | $8K | $0 | $2K | $0 | $10.11M |
| Goodwill | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $3K | $2.81M | $1.56M | $871K | $293K |
| Total Long-Term Assets | $11K | $2.81M | $1.56M | $871K | $10.4M |
| Other Assets | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $3.77M | $3.07M | $1.89M | $1.03M | $11.36M |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | $7.34M | $4.95M | $3.99M | $3.43M | $3.26M |
| Short-Term Debt | $6.94M | $48.21M | $40.4M | $31.03M | $15.01M |
| Current Income Tax Payable | $1.95M | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $4.07M | $3.47M | $1.96M | $584K | $2.42M |
| Total Current Liabilities | $22.26M | $57.13M | $46.74M | $35.65M | $21.61M |
| Long-Term Liabilities | |||||
| Long-Term Debt | $7.88M | $0 | $0 | $0 | $1.19M |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $298K | $65.15M | $65.15M | $65.15M | $65.15M |
| Total Long-Term Liabilities | $8.18M | $65.15M | $65.15M | $65.15M | $73.41M |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $30.43M | $122.28M | $111.89M | $100.8M | $95.02M |
| Stockholders' Equity | |||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 | $0 |
| Retained Earnings | -$160.78M | -$124.96M | -$115.73M | -$105.45M | -$85.23M |
| Comprehensive Income & Other | $0 | $0 | $0 | $0 | $0 |
| Other Stockholders' Equity | $134.12M | $5.75M | $5.73M | $5.68M | $1.57M |
| Total Equity | -$26.66M | -$119.2M | -$110M | -$99.77M | -$83.66M |
| Minority Interest | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $3.77M | $3.07M | $1.89M | $1.03M | $11.36M |
| Supplementary Data | |||||
| Total Debt | $14.81M | $48.21M | $40.4M | $31.03M | $24.02M |
| Net Debt | $13.04M | $48.02M | $40.25M | $30.95M | $23.16M |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Operating Activities | |||||
| Net Income | -$35.82M | -$9.23M | -$10.28M | -$20.22M | -$10.31M |
| Depreciation & Amortization | $0 | $0 | $0 | $724K | $1.18M |
| Deferred Income Tax | $0 | $0 | $0 | $0 | $0 |
| Stock-Based Compensation | $891K | $21K | $33K | $111K | $72K |
| Changes in Working Capital: | |||||
| Accounts Receivable | $0 | $45K | -$45K | $38K | $371K |
| Inventory | $0 | $0 | $0 | $0 | $0 |
| Accounts Payable | $3.56M | $645K | $533K | $706K | -$60K |
| Other Working Capital | $786K | $1.72M | $1.05M | $165K | -$833K |
| Total Working Capital Change | $4.35M | $2.41M | $1.54M | $909K | -$522K |
| Other Non-Cash Items | $14.34M | $4.74M | $4.3M | $10.77M | -$1.11M |
| Net Cash from Operating | -$16.25M | -$2.07M | -$4.4M | -$7.7M | -$10.69M |
| Investing Activities | |||||
| Capital Expenditures | -$8K | $0 | -$2K | $0 | $0 |
| Acquisitions | $0 | $0 | $0 | $0 | $0 |
| Purchases of Investments | -$2M | $0 | $0 | $0 | $0 |
| Sales of Investments | $0 | $0 | $0 | $0 | $0 |
| Other Investing Activities | $0 | $0 | $0 | $0 | $0 |
| Net Cash from Investing | -$2.01M | $0 | -$2K | $0 | $0 |
| Financing Activities | |||||
| Debt Repaid | - | - | - | - | -$1.3M |
| Common Stock Issuance | $0 | $0 | $0 | $0 | $0 |
| Common Stock Repurchases | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | $10.28M | -$961K | -$591K | -$772K | $51K |
| Net Cash from Financing | $19.84M | $2.12M | $4.47M | $6.92M | $8.75M |
| Forex Effect | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | $1.59M | $49K | $64K | -$778K | -$1.94M |
| Supplementary Data | |||||
| Operating Cash Flow | -$16.25M | -$2.07M | -$4.4M | -$7.7M | -$10.69M |
| Capital Expenditure | -$8K | $0 | -$2K | $0 | $0 |
| Free Cash Flow | -$16.26M | -$2.07M | -$4.4M | -$7.7M | -$10.69M |
| Cash at Beginning | $191K | $142K | $78K | $856K | $2.8M |
| Cash at End | $1.78M | $191K | $142K | $78K | $856K |